ANSWER AND REASONINGE. Urgent repeated surgical debridement plus systemic antifungal treatment and reversal of immunosuppression where possible
Mucormycosis is angioinvasive; survival depends on rapid combined source control, antifungal therapy and correction of host factors.
Why every option is right or wrong
A. Wait for final culture before treatment: Culture sensitivity is limited and delay is dangerous after histological confirmation.
B. Topical antifungal drops alone: They cannot treat angioinvasive skull-base and orbital disease.
C. Orbital exenteration in every patient: Radical orbital surgery is selected by disease extent and response, not automatic.
D. Steroids for presumed orbital inflammation: Immunosuppression can accelerate fungal invasion.
E. Urgent repeated surgical debridement plus systemic antifungal treatment and reversal of immunosuppression where possible: Mucormycosis is angioinvasive; survival depends on rapid combined source control, antifungal therapy and correction of host factors.
What if the scenario changed?
If septate acute-angle branching hyphae suggested Aspergillus, antifungal selection would change while urgent debridement remained essential.